Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019
- PMID: 34080543
- PMCID: PMC8380631
- DOI: 10.1016/j.jsat.2021.108372
Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019
Abstract
Introduction: The purpose of this study is to assess community pharmacists' attitudes and experiences related to naloxone dispensation and counseling in non-urban areas in New York State to better understand individual and structural factors that influence pharmacy provision of naloxone.
Materials and methods: The study conducted interviewer-administered semistructured surveys among community pharmacists in retail, independent, and supermarket pharmacies between October 2019 and December 2019. The 29-item survey ascertained pharmacists' demographic and practice characteristics; experiences and beliefs related to naloxone dispensation; and attitudes toward expansion of pharmacy services to include on-site public health services for persons who use opioids. The study used Chi square tests to determine associations between each characteristic and self-reported naloxone dispensation (any vs. none).
Results: A total of 60 of the 80 community pharmacists that the study team had approached agreed to participate. A majority were supportive of expanding pharmacy-based access to vaccinations (93.3%), on-site HIV testing, or referrals (75% and 96.7%, respectively), providing information on safe syringe use (93.3%) and disposal (98.3%), and referrals to medical/social services (88.3%), specifically substance use treatment (90%). A majority of pharmacist respondents denied negative impacts on business with over half reporting active naloxone dispensation (58.3%). Pharmacists dispensing naloxone were more likely to be multilingual (p < 0.03), and to specifically support on-site HIV testing (p < 0.02) than those who were not dispensing naloxone.
Discussion: Community pharmacists were highly favorable of naloxone dispensation in rural and small metro area pharmacies in NY, and those fluent in additional language(s) and supportive of on-site HIV testing were associated with active naloxone dispensation. While active naloxone dispensation was low, pharmacists appear supportive of a "frontline public health provider" model, which could facilitate naloxone uptake and warrants large-scale investigation.
Conclusion: Rural and small metro area pharmacists are generally favorable of naloxone dispensation.
Keywords: Naloxone; Opioid use disorder; Pharmacies; Vulnerable populations.
Copyright © 2021 Elsevier Inc. All rights reserved.
References
-
- Bakhireva LN, Bautista A, Cano S, Shrestha S, Bachyrycz AM, & Cruz TH (2018). Barriers and facilitators to dispensing of intranasal naloxone by pharmacists. 39(3), 331–341. - PubMed
-
- Cochran G, Field C, Lawson K, & Erickson C. (2013). Pharmacists’ knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of U tah and T exas pharmacists. 4(2), 71–79.
-
- Crawford ND, Blaney S, Amesty S, Rivera AV, Turner AK, Ompad DC, & Fuller C. (2011). Individual-and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists’ role in reducing racial/ethnic disparities in influenza vaccinations in New York City. 88(1), 176–185. - PMC - PubMed
-
- Egan KL, Foster SE, Knudsen AN, & Lee JG (2020). Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in Access. American journal of preventive medicine. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
